Oracle Corporation has elected Dr. Tomislav Mihaljevic, CEO of Cleveland Clinic, to its Board of Directors, increasing the board size to 13 members. Dr. Mihaljevic brings extensive healthcare leadership experience, including managing complex clinical organizations and advancing patient care globally. His expertise is expected to support Oracle's efforts in leveraging technology to improve healthcare outcomes. The new board term will last until the next annual stockholder meeting in November 2026.
Oracle and Microsoft, two leaders in enterprise software and AI infrastructure, have seen their stocks lag despite strong earnings and growth in AI-related revenue. Oracle faces concerns over high capital expenditures and debt but boasts a $553 billi...
The surge in artificial intelligence (AI) capital spending is historic, with 2026 estimates nearly doubling to $725 billion, driven by major tech companies known as hyperscalers. This massive investment requires significant energy, benefiting natural...
Ishan Technologies, an Indian ICT leader, has partnered with Oracle Communications to drive a comprehensive digital transformation. This initiative will modernize Ishan's charging and billing systems, enabling faster rollout of new digital services, ...
The current surge in capital expenditures (CapEx) driven by AI investments is propelling semiconductor stocks to outperform the market. However, major hyperscalers like Meta, Amazon, and Oracle are taking on significant debt and risking negative free...
The AI-driven stock rally is expanding beyond core AI companies to include AI-adjacent firms like Qualcomm, Datadog, and Oracle, with some stocks surging 20-70% in a month despite mixed earnings results. This broad enthusiasm has raised concerns abou...
